ISoP Sky Background

International Society of Pharmacovigilance

At the forefront of Pharmacovigilance around the world


What is ISoP?

The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…

ISoP 2017

ISOP Liverpool 2017

Annual Meeting

ACC, Liverpool, 15-18 October 2017 “Pharmacovigilance in the 21st Century” Register Now!
ISoP 2017 Liverpool

ISoP Training

Mid Year Training

Canberra, Australia, 15-16 March 2018
Pharmacovigilance in the Western Pacific:
Global approaches to risk-management of medicines.

ISoP-Mid Year 2017 Bangkok


Education Training Programme

Education Training Programme
A primary objective of ISoP is to promote the safest use of drugs through contributing to appropriate education. Educational Training Link

ISoP Seminar
Boston, USA

4-5 December 2017

Intelligent Automation in PharmacovigilanceREGISTER INTEREST

What’s New


We are deeply saddened to report the death of Professor Giampaolo Velo past ISoP President (2003-2006)

PV Professional Qualification Framework Group

More information, click here

The New Phase of ISoP

Article published in Drug Safety

Herbal and Traditional Medicines Group

More information, click here

ISoP Monograph

‘Pharmacovigilance – Critique and Ways Forward’

New ISoP Statutes

Click here

WHO-ISoP PV Curriculum

PV Curriculum Databank Pilot



Release of the new ‘ International Ethical Guidelines for Health-related Research involving Humans ‘ Click here
A number of free CIOMS publications are now available in CIOMS new e-shop

Sten Olsson
President ISoP

President of ISoP

ISoP is becoming a mature organization, having gone through generations of development since the early 1990s, and is right now entering into a new phase.


Drug Safety

ISoP Official Journal


Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.